150 related articles for article (PubMed ID: 10083655)
21. [A case of intense cytolysis following the administration of a hepatitis B vaccine].
Lasheras Carbajo MD; Palacios Díez M; González Diego P; Martín Scapa MA; Cano Ruiz A; Asensio Vegas A
Rev Clin Esp; 1999 Jan; 199(1):49-50. PubMed ID: 10089783
[No Abstract] [Full Text] [Related]
22. Vaccinations and multiple sclerosis.
Hostetler L
N Engl J Med; 2001 Jun; 344(23):1795. PubMed ID: 11396456
[No Abstract] [Full Text] [Related]
23. Arthus reaction to recombinant hepatitis B virus vaccine.
Froehlich H; Verma R
Clin Infect Dis; 2001 Sep; 33(6):906-8. PubMed ID: 11512098
[TBL] [Abstract][Full Text] [Related]
24. [Central nervous system demyelinating events and hepatitis B vaccine: a new episode of the never ending French saga!].
Costagliola D
Rev Epidemiol Sante Publique; 2008 Dec; 56(6):379-81. PubMed ID: 19019601
[No Abstract] [Full Text] [Related]
25. Vaccinations and multiple sclerosis.
Bégaud B; Alpérovitch A
N Engl J Med; 2001 Jun; 344(23):1793; author reply 1795. PubMed ID: 11396452
[No Abstract] [Full Text] [Related]
26. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
[TBL] [Abstract][Full Text] [Related]
27. Vaccinations and multiple sclerosis.
Hanslik T; Viboud C; Flahault A
N Engl J Med; 2001 Jun; 344(23):1793-4; author reply 1795-6. PubMed ID: 11396451
[No Abstract] [Full Text] [Related]
28. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B vaccination and multiple sclerosis: the jury is still out.
Hernán MA; Jick SS
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):653-5. PubMed ID: 16245367
[No Abstract] [Full Text] [Related]
30. Prolonged Hepatitis B surface antigen positivity in Hepatitis B vaccine recipients.
Sharma S; Saini N; Arora L; Chawla Y; Duseja A
Dig Liver Dis; 2006 Nov; 38(11):860-1. PubMed ID: 16884965
[No Abstract] [Full Text] [Related]
31. Vaccinations and risk of central nervous system demyelinating diseases in adults.
DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
[TBL] [Abstract][Full Text] [Related]
32. Guillain - Barre' syndrome following recombinant hepatitis B vaccine and literature review.
Sinsawaiwong S; Thampanitchawong P
J Med Assoc Thai; 2000 Sep; 83(9):1124-6. PubMed ID: 11075984
[TBL] [Abstract][Full Text] [Related]
33. [Vaccination against hepatitis B or chasing shadows].
Sicard D
Rev Med Interne; 1999 Feb; 20(2):119-20. PubMed ID: 10227088
[No Abstract] [Full Text] [Related]
34. Multiple sclerosis and hepatitis B vaccination: could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry?
Faure E
Med Hypotheses; 2005; 65(3):509-20. PubMed ID: 15908138
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
37. Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Martínez-Sernández V; Figueiras A
J Neurol; 2013 Aug; 260(8):1951-9. PubMed ID: 23086181
[TBL] [Abstract][Full Text] [Related]
38. [Controversy about a vaccine].
Criel C
Soins Psychiatr; 1998; (197):suppl IV. PubMed ID: 9775976
[No Abstract] [Full Text] [Related]
39. [Hemolytic anemia and thrombocytopenic purpura after the administration of the recombinant hepatitis B vaccine].
Llimiñana C; Soler JA; Melo M; Roig I
Med Clin (Barc); 1999 Jun; 113(1):39. PubMed ID: 10422080
[No Abstract] [Full Text] [Related]
40. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
